NOSTRAND ROBERT L VAN Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for NOSTRAND ROBERT L VAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of NOSTRAND ROBERT L VAN. NOSTRAND ROBERT L VAN is VP, & Chief Financial Officer in OSI PHARMACEUTICALS INC ($OSIP) and Director in METABOLIX, INC. ($MBLX) and in ACHILLION PHARMACEUTICALS INC ($ACHN) and Director in ACHILLION PHARMACEUTICALS INC ($ACHN) and Director in SELLAS Life Sciences Group, Inc. ($GALE) and Director in Enumeral Biomedical Holdings, Inc. ($ENUM) and Director in Intra-Cellular Therapies, Inc. ($ITCI).
Latest Insider Trading Transactions of NOSTRAND ROBERT L VAN
Sentiment: All, ACHN, ENUM, ITCI, OSIP, SLS, MBLX
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 48.03 | 31 | 1,489 | 6,653 | 6.7 K to 6.7 K (-0.46 %) |
| Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 48.02 | 140 | 6,723 | 6,684 | 6.8 K to 6.7 K (-2.05 %) |
| Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 48.01 | 187 | 8,978 | 6,824 | 7 K to 6.8 K (-2.67 %) |
| Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 48.00 | 140 | 6,720 | 7,011 | 7.2 K to 7 K (-1.96 %) |
| Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 47.99 | 78 | 3,743 | 7,151 | 7.2 K to 7.2 K (-1.08 %) |
| Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 47.98 | 140 | 6,717 | 7,229 | 7.4 K to 7.2 K (-1.90 %) |
| Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 47.97 | 233 | 11,177 | 7,369 | 7.6 K to 7.4 K (-3.06 %) |
| Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 47.95 | 47 | 2,254 | 7,602 | 7.6 K to 7.6 K (-0.61 %) |
| Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Buy | M | 7.09 | 2,750 | 19,509 | 7,649 | 4.9 K to 7.6 K (+56.13 %) |
| Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Grant | A | 58.16 | 10 | 582 | 4,899 | 4.9 K to 4.9 K (+0.20 %) |
| Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Option Exercise | M | 7.09 | 2,750 | 19,509 | 8,405 | |
| Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 64.83 | 171 | 11,086 | 4,766 | 4.9 K to 4.8 K (-3.46 %) |
| Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 64.60 | 181 | 11,693 | 4,937 | 5.1 K to 4.9 K (-3.54 %) |
| Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 64.54 | 19 | 1,226 | 5,118 | 5.1 K to 5.1 K (-0.37 %) |
| Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 64.53 | 19 | 1,226 | 5,137 | 5.2 K to 5.1 K (-0.37 %) |
| Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 64.52 | 75 | 4,839 | 5,156 | 5.2 K to 5.2 K (-1.43 %) |
| Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 64.49 | 48 | 3,096 | 5,231 | 5.3 K to 5.2 K (-0.91 %) |
| Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 64.40 | 38 | 2,447 | 5,279 | 5.3 K to 5.3 K (-0.71 %) |
| Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 64.32 | 29 | 1,865 | 5,317 | 5.3 K to 5.3 K (-0.54 %) |
| Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 64.31 | 18 | 1,158 | 5,346 | 5.4 K to 5.3 K (-0.34 %) |
| Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 64.30 | 722 | 46,425 | 5,364 | 6.1 K to 5.4 K (-11.86 %) |
| Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 64.25 | 1,192 | 76,586 | 6,086 | 7.3 K to 6.1 K (-16.38 %) |
| Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 64.21 | 48 | 3,082 | 7,278 | 7.3 K to 7.3 K (-0.66 %) |
| Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 64.20 | 190 | 12,198 | 7,326 | 7.5 K to 7.3 K (-2.53 %) |
| Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Buy | M | 7.09 | 2,750 | 19,509 | 7,516 | 4.8 K to 7.5 K (+57.70 %) |
| Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Option Exercise | M | 7.09 | 2,750 | 19,509 | 11,155 | |
| Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 61.83 | 111 | 6,863 | 4,766 | 4.9 K to 4.8 K (-2.28 %) |
| Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 61.75 | 25 | 1,544 | 4,877 | 4.9 K to 4.9 K (-0.51 %) |
| Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 61.60 | 197 | 12,135 | 4,902 | 5.1 K to 4.9 K (-3.86 %) |
| Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 61.55 | 99 | 6,093 | 5,099 | 5.2 K to 5.1 K (-1.90 %) |
| Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 61.30 | 49 | 3,004 | 5,198 | 5.2 K to 5.2 K (-0.93 %) |
| Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 61.25 | 12 | 735 | 5,247 | 5.3 K to 5.2 K (-0.23 %) |
| Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 61.19 | 12 | 734 | 5,259 | 5.3 K to 5.3 K (-0.23 %) |
| Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 61.18 | 49 | 2,998 | 5,271 | 5.3 K to 5.3 K (-0.92 %) |
| Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 61.11 | 12 | 733 | 5,320 | 5.3 K to 5.3 K (-0.23 %) |
| Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 61.10 | 320 | 19,552 | 5,332 | 5.7 K to 5.3 K (-5.66 %) |
| Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 61.09 | 37 | 2,260 | 5,652 | 5.7 K to 5.7 K (-0.65 %) |
| Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 61.07 | 49 | 2,992 | 5,698 | 5.7 K to 5.7 K (-0.85 %) |
| Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 61.05 | 37 | 2,259 | 5,738 | 5.8 K to 5.7 K (-0.64 %) |
| Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 61.00 | 287 | 17,507 | 5,775 | 6.1 K to 5.8 K (-4.73 %) |
| Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 60.96 | 1,231 | 75,042 | 6,062 | 7.3 K to 6.1 K (-16.88 %) |
| Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 60.83 | 12 | 730 | 7,293 | 7.3 K to 7.3 K (-0.16 %) |
| Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 60.81 | 25 | 1,520 | 7,305 | 7.3 K to 7.3 K (-0.34 %) |
| Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 60.80 | 62 | 3,770 | 7,330 | 7.4 K to 7.3 K (-0.84 %) |
| Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 60.78 | 12 | 729 | 7,392 | 7.4 K to 7.4 K (-0.16 %) |
| Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 60.77 | 25 | 1,519 | 7,404 | 7.4 K to 7.4 K (-0.34 %) |
| Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 60.76 | 38 | 2,309 | 7,429 | 7.5 K to 7.4 K (-0.51 %) |
| Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 60.75 | 49 | 2,977 | 7,467 | 7.5 K to 7.5 K (-0.65 %) |
| Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Buy | M | 7.09 | 2,750 | 19,509 | 7,516 | 4.8 K to 7.5 K (+57.70 %) |
| Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Option Exercise | M | 7.09 | 2,750 | 19,509 | 13,905 | |
| Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 59.45 | 230 | 13,674 | 4,766 | 5 K to 4.8 K (-4.60 %) |
| Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 59.40 | 204 | 12,118 | 4,996 | 5.2 K to 5 K (-3.92 %) |
| Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 59.18 | 370 | 21,897 | 5,200 | 5.6 K to 5.2 K (-6.64 %) |
| Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 59.16 | 125 | 7,395 | 5,570 | 5.7 K to 5.6 K (-2.19 %) |
| Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 59.12 | 1,035 | 61,189 | 5,695 | 6.7 K to 5.7 K (-15.38 %) |
| Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 59.02 | 320 | 18,886 | 6,730 | 7.1 K to 6.7 K (-4.54 %) |
| Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 59.01 | 12 | 708 | 7,050 | 7.1 K to 7.1 K (-0.17 %) |
| Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 59.00 | 377 | 22,243 | 7,062 | 7.4 K to 7.1 K (-5.07 %) |
| Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 58.99 | 26 | 1,534 | 7,439 | 7.5 K to 7.4 K (-0.35 %) |
| Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 58.98 | 51 | 3,008 | 7,465 | 7.5 K to 7.5 K (-0.68 %) |
| Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Buy | M | 7.09 | 2,750 | 19,509 | 7,516 | 4.8 K to 7.5 K (+57.70 %) |
| Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Option Exercise | M | 7.09 | 345 | 2,447 | 16,655 | |
| Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Option Exercise | M | 9.00 | 2,405 | 21,645 | 0 | |
| Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 58.61 | 238 | 13,949 | 4,766 | 5 K to 4.8 K (-4.76 %) |
| Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 58.52 | 36 | 2,107 | 5,004 | 5 K to 5 K (-0.71 %) |
| Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 58.50 | 273 | 15,971 | 5,040 | 5.3 K to 5 K (-5.14 %) |
| Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 58.33 | 670 | 39,081 | 5,313 | 6 K to 5.3 K (-11.20 %) |
| Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 58.24 | 24 | 1,398 | 5,983 | 6 K to 6 K (-0.40 %) |
| Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 58.23 | 36 | 2,096 | 6,007 | 6 K to 6 K (-0.60 %) |
| Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 58.22 | 24 | 1,397 | 6,043 | 6.1 K to 6 K (-0.40 %) |
| Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 58.21 | 12 | 699 | 6,067 | 6.1 K to 6.1 K (-0.20 %) |
| Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 58.20 | 416 | 24,211 | 6,079 | 6.5 K to 6.1 K (-6.40 %) |
| Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 58.17 | 12 | 698 | 6,495 | 6.5 K to 6.5 K (-0.18 %) |
| Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 58.16 | 60 | 3,490 | 6,507 | 6.6 K to 6.5 K (-0.91 %) |
| Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 58.14 | 21 | 1,221 | 6,567 | 6.6 K to 6.6 K (-0.32 %) |
| Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 58.12 | 12 | 697 | 6,588 | 6.6 K to 6.6 K (-0.18 %) |
| Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 58.10 | 131 | 7,611 | 6,600 | 6.7 K to 6.6 K (-1.95 %) |
| Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 57.82 | 24 | 1,388 | 6,731 | 6.8 K to 6.7 K (-0.36 %) |
| Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 57.81 | 143 | 8,267 | 6,755 | 6.9 K to 6.8 K (-2.07 %) |
| Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 57.80 | 12 | 694 | 6,898 | 6.9 K to 6.9 K (-0.17 %) |
| Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 57.76 | 24 | 1,386 | 6,910 | 6.9 K to 6.9 K (-0.35 %) |
| Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 57.75 | 582 | 33,611 | 6,934 | 7.5 K to 6.9 K (-7.74 %) |
| Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Buy | M | 7.09 | 345 | 2,447 | 7,516 | 7.2 K to 7.5 K (+4.81 %) |
| Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Buy | M | 9.00 | 2,405 | 21,645 | 7,171 | 4.8 K to 7.2 K (+50.46 %) |
| Jul 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Option Exercise | M | 9.00 | 2,750 | 24,750 | 2,405 | |
| Jul 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 70.00 | 18 | 1,260 | 4,766 | 4.8 K to 4.8 K (-0.38 %) |
| Jul 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 69.97 | 48 | 3,359 | 4,784 | 4.8 K to 4.8 K (-0.99 %) |
| Jul 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 69.96 | 240 | 16,790 | 4,832 | 5.1 K to 4.8 K (-4.73 %) |
| Jul 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 69.95 | 1,997 | 139,690 | 5,072 | 7.1 K to 5.1 K (-28.25 %) |
| Jul 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 69.52 | 447 | 31,075 | 7,069 | 7.5 K to 7.1 K (-5.95 %) |
| Jul 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Buy | M | 9.00 | 2,750 | 24,750 | 7,516 | 4.8 K to 7.5 K (+57.70 %) |
| Jun 21 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Option Exercise | A | 67.63 | 17,100 | 1,156,473 | 17,100 | |
| Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Option Exercise | M | 9.00 | 2,750 | 24,750 | 5,155 | |
| Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 81.81 | 22 | 1,800 | 4,766 | 4.8 K to 4.8 K (-0.46 %) |
| Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 81.80 | 33 | 2,699 | 4,788 | 4.8 K to 4.8 K (-0.68 %) |
| Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 81.70 | 167 | 13,644 | 4,821 | 5 K to 4.8 K (-3.35 %) |
| Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 81.55 | 135 | 11,010 | 4,988 | 5.1 K to 5 K (-2.64 %) |
| Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 81.52 | 33 | 2,690 | 5,123 | 5.2 K to 5.1 K (-0.64 %) |
| Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 81.50 | 623 | 50,775 | 5,156 | 5.8 K to 5.2 K (-10.78 %) |
| Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 81.34 | 178 | 14,478 | 5,779 | 6 K to 5.8 K (-2.99 %) |
| Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 81.30 | 293 | 23,821 | 5,957 | 6.3 K to 6 K (-4.69 %) |
| Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 81.20 | 31 | 2,517 | 6,250 | 6.3 K to 6.3 K (-0.49 %) |
| Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 81.06 | 289 | 23,425 | 6,281 | 6.6 K to 6.3 K (-4.40 %) |
| Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 81.00 | 946 | 76,626 | 6,570 | 7.5 K to 6.6 K (-12.59 %) |
| Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Buy | M | 9.00 | 2,750 | 24,750 | 7,516 | 4.8 K to 7.5 K (+57.70 %) |
| May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Option Exercise | M | 9.00 | 2,750 | 24,750 | 7,905 | |
| May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 73.51 | 562 | 41,313 | 4,766 | 5.3 K to 4.8 K (-10.55 %) |
| May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 73.50 | 1,492 | 109,662 | 5,328 | 6.8 K to 5.3 K (-21.88 %) |
| May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 73.42 | 321 | 23,569 | 6,820 | 7.1 K to 6.8 K (-4.50 %) |
| May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 72.93 | 95 | 6,928 | 7,141 | 7.2 K to 7.1 K (-1.31 %) |
| May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 72.62 | 49 | 3,559 | 7,236 | 7.3 K to 7.2 K (-0.67 %) |
| May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 72.55 | 48 | 3,482 | 7,285 | 7.3 K to 7.3 K (-0.65 %) |
| May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 72.51 | 112 | 8,122 | 7,333 | 7.4 K to 7.3 K (-1.50 %) |
| May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 72.50 | 71 | 5,148 | 7,445 | 7.5 K to 7.4 K (-0.94 %) |
| May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Buy | M | 9.00 | 2,750 | 24,750 | 7,516 | 4.8 K to 7.5 K (+57.70 %) |
| Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Option Exercise | M | 9.00 | 1,250 | 11,250 | 10,655 | |
| Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 82.30 | 255 | 20,988 | 4,766 | 5 K to 4.8 K (-5.08 %) |
| Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 81.61 | 162 | 13,220 | 5,021 | 5.2 K to 5 K (-3.13 %) |
| Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 80.90 | 156 | 12,620 | 5,183 | 5.3 K to 5.2 K (-2.92 %) |
| Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 80.70 | 630 | 50,841 | 5,339 | 6 K to 5.3 K (-10.55 %) |
| Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 80.50 | 47 | 3,784 | 5,969 | 6 K to 6 K (-0.78 %) |
| Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Buy | M | 9.00 | 1,250 | 11,250 | 6,016 | 4.8 K to 6 K (+26.23 %) |
| Apr 21 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Option Exercise | M | 9.00 | 833 | 7,497 | 11,905 | |
| Apr 21 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 40.00 | 833 | 33,320 | 4,766 | 5.6 K to 4.8 K (-14.88 %) |
| Apr 21 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Buy | M | 9.00 | 833 | 7,497 | 5,599 | 4.8 K to 5.6 K (+17.48 %) |
| Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Option Exercise | M | 9.00 | 667 | 6,003 | 12,738 | |
| Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 38.34 | 29 | 1,112 | 4,766 | 4.8 K to 4.8 K (-0.60 %) |
| Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 38.33 | 32 | 1,227 | 4,795 | 4.8 K to 4.8 K (-0.66 %) |
| Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 38.30 | 218 | 8,349 | 4,827 | 5 K to 4.8 K (-4.32 %) |
| Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 38.25 | 52 | 1,989 | 5,045 | 5.1 K to 5 K (-1.02 %) |
| Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 38.24 | 285 | 10,898 | 5,097 | 5.4 K to 5.1 K (-5.30 %) |
| Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 38.23 | 14 | 535 | 5,382 | 5.4 K to 5.4 K (-0.26 %) |
| Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 38.20 | 35 | 1,337 | 5,396 | 5.4 K to 5.4 K (-0.64 %) |
| Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 38.18 | 2 | 76 | 5,431 | 5.4 K to 5.4 K (-0.04 %) |
| Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Buy | M | 9.00 | 667 | 6,003 | 5,433 | 4.8 K to 5.4 K (+13.99 %) |